Alamo Group has acquired Econ Engineering Group Limited, a UK-based manufacturer of roadway maintenance trucks and equipment, for £120 million ($158.7 million). Econ, founded in 1969, produces vehicles like gritters and de-icing trucks and operates a rental fleet, serving UK local authorities and government agencies. This acquisition strengthens Alamo Group's Industrial Equipment Division and expands its presence in the UK market, with plans to grow Econ's business beyond its current scope. The deal was funded through Alamo's revolving credit facility and aligns with its strategy to invest in market-leading infrastructure and maintenance businesses.
Alamo Group's acquisition of Econ Engineering is presented here with Industrials-sector market data from Pluang. For readers following Industrials, as of Oct 28, 2026 03:12 WIB, 84 of 135 priced US stocks rose while 51 fell. Notable movers include AMSC at USD 27.66 with an 8.90% gain and a typical hold time of 35 days, RKLB at USD 58.41 with an 8.53% gain but 95% sell order activity, and SMR at USD 5.71 with an 8.35% gain and 94% buy order activity, typical hold time 32 days.
The global drone defense system market is projected to grow from $4.72 billion in 2025 to $18.19 billion by 2030, driven by increasing unauthorized drone incidents and demand for advanced detection and countermeasure technologies. Growth is fueled by...
Eli Lilly has outpaced Novo Nordisk in the GLP-1, obesity, and Type 2 Diabetes market, achieving a $1.21 trillion valuation. While Novo Nordisk's share price has fallen back after earlier gains and revenue growth remains flat, its management's strate...
argenx SE announced it will stop its Phase 3 UNITY study of efgartigimod subcutaneous for moderate-to-severe Sjögren's disease after an independent committee found the trial unlikely to meet its primary goal. This decision caused the company's stock ...
Pomerantz LLP is investigating DaVita Inc. for potential securities fraud following a sharp stock price drop triggered by a new U.S. federal strategy targeting the dialysis market. The Department of Health and Human Services announced a plan to incre...
Pomerantz LLP is investigating ClearPoint Neuro and its executives for possible securities fraud following a significant stock price drop. The decline occurred after ClearPoint's partner, uniQure, announced that their Huntington's disease treatment f...
